business.financialpost.com
Valeant Pharmaceuticals International Inc’s biggest deal yet seen as a bet on FDA decision on Salix’s blockbuster drug
Valeant, which was thwarted last year in a long-running quest to buy Botox-maker Allergan Inc., is counting on Salix’s gastrointestinal drug getting U.S. Food and Drug Administration approval by Ma…